EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cerebral cortical encephalitis in adults with myelin oligodendrocyte glycoprotein antibody‐associated disease: A national case series

Samuel Pace, Silvia Messina, Bo Chen, Radu Tanasescu, Athanasios Papathanasiou, Cris S Constantinescu iD, Maria I Leite, Mark D Willis, Janet A Johnston, Jacqueline Palace, Ruth Dobson iD

European Journal of Neurology · 2025-01 · 32 (1)

DOI: 10.1111/ene.16550 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, online erschienen am 19.11.2024. Verfasst von Samuel Pace und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. Hauptthemen laut MEDLINE: Myelin-Oligodendrocyte Glycoprotein, Autoantibodies, Encephalitis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and purpose Myelin oligodendrocyte glycoprotein (MOG) antibody‐associated disease (MOGAD) is a relatively recently described disease, most commonly presenting with optic neuritis and longitudinally extensive transverse myelitis. Cerebral cortical encephalitis is a rare manifestation of MOGAD.

Methods

We identified patients presenting with cerebral cortical encephalitis with positive MOG antibodies in serum across a large specialized service. Demographic and clinical information were collected. We describe clinical and laboratory characteristics, treatment response, and subsequent relapse risk in adults presenting with this phenotype.

Results

We identified eight patients meeting clinical criteria for cerebral cortical encephalitis with MOG antibodies. All had seizures; four had focal onset seizures with or without secondary generalization. Two patients exhibited encephalopathy, and six demonstrated focal neurological deficits at presentation. All had fluid‐attenuated inversion recovery hyperintensities. Five of eight displayed cerebral swelling, and two of eight displayed leptomeningeal enhancement. Where cerebrospinal fluid (CSF) results were available, five of seven had CSF pleocytosis, protein was raised in two of seven, and one patient had oligoclonal bands unique to CSF. Median time to seizure control was 1.25 months, and all clinical features and magnetic resonance imaging abnormalities resolved. Four of eight patients (50%) had a clinical relapse, with a median time to relapse of 6.4 months.

Conclusions

Cerebral cortical encephalitis appears to share similar CSF findings, steroid responsiveness, and risk of relapse with other clinical manifestations of MOGAD. This informs treatment decisions and patient counselling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myelin-Oligodendrocyte GlycoproteinAutoantibodiesEncephalitisHumansFemaleMaleAdultMiddle AgedAgedCerebral CortexMagnetic Resonance ImagingYoung Adult

Stichwörter der Autor:innen

MOG antibody diseaseMRI findingscerebral cortical encephalitisneuromyelitis optica spectrum disorder

Substanzen

Myelin-Oligodendrocyte GlycoproteinAutoantibodiesMOG protein, human

Autor:innen und Institutionen

  • Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK.
  • Nuffield Department of Clinical Neurosciences, Oxford University Hospitals, Oxford, UK.
  • Neurology Department, Wexham Park Hospital, Frimley Foundation Health Trust, Slough, UK.
  • Department of Neurology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Mental Health and Clinical Neuroscience Academic Unit, University of Nottingham School of Medicine, Nottingham, UK.
  • Department of Neurology, Nottingham University Hospitals NHS Trust, Nottingham, UK.

ORCID-Profile: Cris S Constantinescu, Ruth Dobson

Förderung

  • Medical Research Council

Zitieren

APA

Pace, S., Messina, S., Chen, B., Tanasescu, R., Papathanasiou, A., Constantinescu, C. S., Leite, M. I., Willis, M. D., Johnston, J. A., Palace, J., & Dobson, R. (2025). Cerebral cortical encephalitis in adults with myelin oligodendrocyte glycoprotein antibody‐associated disease: A national case series. European Journal of Neurology, 32(1). https://doi.org/10.1111/ene.16550

Vancouver

Pace S, Messina S, Chen B, Tanasescu R, Papathanasiou A, Constantinescu CS, et al. Cerebral cortical encephalitis in adults with myelin oligodendrocyte glycoprotein antibody‐associated disease: A national case series. European Journal of Neurology. 2025;32(1). doi:10.1111/ene.16550

BibTeX
@article{Pace2025,
  author = {Pace, Samuel and Messina, Silvia and Chen, Bo and Tanasescu, Radu and Papathanasiou, Athanasios and Constantinescu, Cris S and Leite, Maria I and Willis, Mark D and Johnston, Janet A and Palace, Jacqueline and Dobson, Ruth},
  title = {Cerebral cortical encephalitis in adults with myelin oligodendrocyte glycoprotein antibody‐associated disease: A national case series},
  journal = {European Journal of Neurology},
  year = {2025},
  volume = {32},
  number = {1},
  doi = {10.1111/ene.16550}
}
Kostenlos starten →